Epamet 12.5/850 mg – Empagliflozin + Metformin Tablets

Epamet 12.5/850 mg is a prescription antidiabetic combination containing Empagliflozin and Metformin to manage blood glucose levels in adults with type 2 diabetes. Empagliflozin promotes renal glucose excretion, while Metformin reduces hepatic glucose production and improves insulin sensitivity.

Key Benefits

• ✔ Controls Fasting and Postprandial Blood Glucose
• ✔ Supports Weight Management
• ✔ Improves Insulin Sensitivity
• ✔ Reduces Cardiovascular Risk Associated with Type 2 Diabetes
• ✔ Convenient Fixed-Dose Combination Tablet

Composition (Per Tablet)

Indications

Epamet 12.5/850 mg is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus, particularly when monotherapy with Metformin is insufficient.

Dosage & Administration

• Take as prescribed by a healthcare professional.
• Swallow whole with water during or after meals to reduce gastrointestinal discomfort.
• Do not chew or crush the tablets.

Precautions

• Not recommended for patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment.
• Monitor kidney function before and during therapy.
• Inform your doctor if pregnant, breastfeeding, or planning pregnancy.
• May cause dehydration, hypotension, or urinary tract infections; maintain adequate hydration.
• Keep out of reach of children.

Storage Instructions

• Store in a cool, dry place below 25°C.
• Keep tablets in their original container, tightly closed.
• Protect from moisture and direct sunlight.

🌿 Manage Type 2 Diabetes Effectively with Epamet 12.5/850 mg – Empagliflozin + Metformin Combination.